Globus announces research showing superiority of SECURE-C to ACDF at 7 years
Globus Medical announced the results of its seven-year clinical trial follow-up that demonstrate superiority of the SECURE-C Cervical Artificial Disc over the current standard for the treatment of cervical disc disease, anterior cervical discectomy and fusion, or ACDF, based on overall success. SECURE-C is designed for disc reconstruction and motion preservation at the operated disc level, unlike traditional motion-eliminating fusion surgery. "The long-term evidence shown in this study confirms the outstanding results I have seen in my own patients treated with SECURE-C," said Dr. William Beutler, neurosurgeon at the Pennsylvania Spine Institute. "SECURE-C's integrated keel is designed for optimal placement and migration resistance, allowing my patients to better maintain their active lifestyles. SECURE-C is proven to be a superior treatment option to fusion for patients with cervical disc disease."